Did Linda Dong pay anything per share for the new FLGT restricted stock units?

No cash payment per share is indicated for the grant. The Form 4 lists a transaction price of $0.0000 per share, reflecting that the 11,117 restricted stock units were awarded as compensation rather than purchased in the open market.

Fulgent Genetics (NASDAQ: FLGT) director receives 11,117 RSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Dong Linda reported acquisition or exercise transactions in this Form 4 filing.

Fulgent Genetics director Linda Dong reported receiving 11,117 shares of Common Stock as a grant of restricted stock units at no cash cost. The award vests over four years, with 1/4 vesting 12 months after May 14, 2026 and the rest quarterly, leaving her with 38,758 directly held shares after the grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dong Linda

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,117	$0.00	--

Holdings After Transaction: Common Stock — 38,758 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 11,117 shares Grant price per share: $0.0000 per share Shares after transaction: 38,758 shares +3 more

6 metrics

RSU grant size 11,117 shares Restricted stock units awarded to director Linda Dong

Grant price per share $0.0000 per share Compensation grant, not an open-market purchase

Shares after transaction 38,758 shares Total directly held by Linda Dong following the grant

Initial vesting tranche 1/4 of 11,117 shares Vests 12 months after May 14, 2026

Ongoing vesting schedule 1/16 every three months Over the remaining 36 months after initial vesting

Transaction code A Grant, award, or other acquisition of non-derivative Common Stock

Key Terms

Restricted stock units, vesting, transaction code A, non-derivative, +1 more

5 terms

Restricted stock units financial

"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"shares subject to the restricted stock units vest over a period of four years"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

transaction code A regulatory

"transaction_code": "A","transaction_code_description": "Grant, award, or other acquisition""

non-derivative financial

"transaction_type": "non-derivative""

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 06:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dong Linda

(Last)

(First)

(Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE

CALIFORNIA

91731

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/14/2026		A		11,117⁽¹⁾	A	$0	38,758	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.

	/s/ Paul Kim as Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Fulgent Genetics (FLGT) report for Linda Dong?

Fulgent Genetics director Linda Dong received 11,117 restricted stock units of Common Stock as a grant. The award carries no cash exercise price and represents additional compensation, increasing her directly held stake to 38,758 shares after the transaction.

Was Linda Dong’s Form 4 transaction in FLGT stock a market purchase or sale?

The Form 4 shows no market purchase or sale by Linda Dong. It reports an acquisition coded “A,” meaning a grant or award of 11,117 restricted stock units from the company, rather than an open-market trade at a stated price.

How many Fulgent Genetics shares does Linda Dong hold after this RSU grant?

After the reported grant, Linda Dong holds 38,758 shares of Fulgent Genetics Common Stock directly. This figure includes the newly awarded 11,117 restricted stock units, which are subject to vesting conditions over a four-year period starting from May 14, 2026.

What is the vesting schedule for Linda Dong’s 11,117 FLGT restricted stock units?

The 11,117 restricted stock units vest over four years. One-quarter vests 12 months after May 14, 2026, and one-sixteenth vests at the end of each three-month period over the following 36 months, contingent on continued service with Fulgent Genetics.